• Synthon Appoints Paul Roos as Chief Financial Officer More...

• Celgene Corporation (CELG) Announces Appointment of Thomas M. Moriarty as General Counsel More...

• Southwest Research Institute's Canup Elected Member of National Academy of Sciences More...

• Theorem Clinical Research Announces Edward Ian as Executive Director, Clinical Development, for the Asia-Pacific Region More...

• Novo Nordisk A/S (NVO) Steps Up Research to Find Cure for Diabetes, Plans to Hire More Researchers More...

• Supernus Pharmaceuticals Announces Closing of Initial Public Offering More...

• Retrophin, LLC Completes Series A Financing More...

• Stereotaxis, Inc. (STXS) Announces Definitive Agreements to Raise $18.5 Million in Private Placement Financings More...

• Biolex Therapeutics Sells LEX System to Synthon and Initiates Sale of Locteron® More...

• AEterna Zentaris (AEZS), Keryx Biopharmaceuticals (KERX) End Perifosine License Pact; Aeterna to Continue Trials More...

• Celsion Corporation (CLN) Announces ThermoDox® Commercial Supply Agreement With Hisun More...

• NeuroLogica Announces Partnership with MEYTEC GmbH More...

• Aeras Global TB Vaccine Foundation and CanSino to Collaborate on TB Vaccine Development More...

• Breckenridge Pharmaceutical, Inc. Signs Generic Agreement with Zhejiang Huahai Pharmaceuticals Co., Ltd. More...

• Ardea Biosciences, Inc. Announces First Quarter 2012 Financial Results More...

• Anacor Pharmaceuticals, Inc. Announces First Quarter 2012 Financial Results Conference Call and Webcast More...

• Advanced Cell Technology to Host Conference Call to Discuss 2012 First Quarter Results and Provide Corporate Update on Wednesday, May 9th More...

• Biocryst Pharmaceuticals (BCRX) Provides Corporate Update and Reports First Quarter 2012 Financial Results More...

• BioMimetic Therapeutics, Inc. (BMTI) to Report First Quarter 2012 Financial Results on May 9 More...

• Bayer AG (BAY.F) Challenges Nexavar Generic Licence Order More...

• Vertex Pharmaceuticals (MA) (VRTX) Surges as CF Combo Improves Breathing More...

• Roche (RHHBY) Abandons Cholesterol Drug Trial on Poor Results More...

• FDA Lifts Second Hold on Trials of Insmed Incorporated (INSM) Lung Drug More...

• Pfizer Inc. (PFE)'s Pristiq Shows Positive Results in Long-Term Study More...

• Kythera Biopharmaceuticals Announces Presentation of Positive Results from First of Two ATX-101 European Phase III Trials for Reduction of Submental Fat More...

• Talon Therapeutics, Inc. (HNAB) Receives Notification of Three Month PDUFA Date Extension for Marqibo® More...

• Pfizer Inc. (PFE) Arthritis Pill Raises Safety Concerns, FDA Staff Says More...

• Curis, Inc. (CRIS) Announces Collaborator Roche (RHHBY)'s Submission of Erivedge™ for Registration With Australian Regulatory Authority More...

• Nuvo Research Inc. (NRI.TO)'s Pliaglis Receives Positive Opinion from the BfArM in the E.U. More...

• Health Canada Grants Apricus Biosciences (APRI) Pre-NDS Meeting for Femprox for Female Sexual Arousal Disorder More...

• pSivida Corp (PSDV) Announces United Kingdom Grants ILUVIEN® Marketing Authorization for the Treatment of Chronic Diabetic Macular Edema More...

• Eye Color May Indicate Risk for Serious Skin Conditions, University of Colorado Study More...

• Curry's Ability to Fight Cancer Put to the Test, Leicester Royal Infirmary andLeicester General Hospital Study More...

• Range of Brain Diseases Could Be Treated by Single Drug, University of Leicester Study More...

• Massive Rise in Asian Eye Damage, Australian National University Study More...

• Kids With Cerebral Palsy May Benefit from Video Game Play, University of Toronto Study More...

• Sunovion Pharmaceuticals Inc.'s Latuda® (lurasidone HCl) Label Updated With Expanded Dosing Range Providing Added Flexibility for the Treatment of Patients With Schizophrenia More...

• Sunovion Pharmaceuticals Inc. Announces Upcoming Availability of ZETONNA™ (ciclesonide) Nasal Aerosol, a Non-Aqueous, Dry Nasal Aerosol Spray for Allergic Rhinitis More...